Toxicology reports · 2026
Toxicokinetics under extracorporeal clearance and temporal dissociation of hepatotoxicity and coagulopathy in ACDMB poisoning: Two index cases.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jin Kefeng, Wang Peng, Yang Xiuqin, Zhang Xiaofei, Huang Tao, Qiu Yue, Li Mo, Wang Yuan, Ma Xue
Аннотация
BACKGROUND: 2-Amino-5-chloro-N,3-dimethylbenzamide (ACDMB), a synthetic intermediate for the insecticide chlorantraniliprole, causes extremely rare occupational poisoning (six cases worldwide) with unknown human toxicokinetics. We report two consecutive index cases from the same manufacturing facility.Case presentationCase A (22-year-old male) and Case B (37-year-old male) developed fulminant hepatitis following brief accidental occupational exposure. Both received plasma exchange and continuous venovenous hemofiltration; Case A additionally received hemoperfusion. Both achieved full recovery and were discharged on Day 28 (Case A) and Day 14 (Case B), respectively.
RESULTS: Serial serum monitoring in Case B revealed mono-exponential elimination (apparent half-life 18.4 h, 95% CI 15.3-22.1). Both patients exhibited temporal dissociation: peak hepatotoxicity occurred at 54-65 h, whereas critical coagulopathy (Coagulation Reserve Index [CRI] <5) developed later at 123-127 h when > 95% of toxin had been cleared. At comparable CRI nadirs, hemoperfusion in Case A resulted in immediate circuit clotting and prolonged DIC reversal (48 h), whereas cryoprecipitate support in Case B achieved rapid recovery (8.3 h) without adsorptive therapy.
CONCLUSION: These observations provide the first human ACDMB toxicokinetic profile under extracorporeal clearance and generate the hypothesis that CRI < 5 may identify high-risk periods for hemoperfusion, though prospective validation is required.
RESULTS: Serial serum monitoring in Case B revealed mono-exponential elimination (apparent half-life 18.4 h, 95% CI 15.3-22.1). Both patients exhibited temporal dissociation: peak hepatotoxicity occurred at 54-65 h, whereas critical coagulopathy (Coagulation Reserve Index [CRI] <5) developed later at 123-127 h when > 95% of toxin had been cleared. At comparable CRI nadirs, hemoperfusion in Case A resulted in immediate circuit clotting and prolonged DIC reversal (48 h), whereas cryoprecipitate support in Case B achieved rapid recovery (8.3 h) without adsorptive therapy.
CONCLUSION: These observations provide the first human ACDMB toxicokinetic profile under extracorporeal clearance and generate the hypothesis that CRI < 5 may identify high-risk periods for hemoperfusion, though prospective validation is required.